VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS10042152 | HBV | ENSG00000035664.11 | protein_coding | DAPK2 | No | No | 23604 | Q9UIK4 |
TVIS10046535 | HBV | ENSG00000035664.11 | protein_coding | DAPK2 | No | No | 23604 | Q9UIK4 |
TVIS30015136 | HIV | ENSG00000035664.11 | protein_coding | DAPK2 | No | No | 23604 | Q9UIK4 |
TVIS30019681 | HIV | ENSG00000035664.11 | protein_coding | DAPK2 | No | No | 23604 | Q9UIK4 |
TVIS20006124 | HPV | ENSG00000035664.11 | protein_coding | DAPK2 | No | No | 23604 | Q9UIK4 |
TVIS20041411 | HPV | ENSG00000035664.11 | protein_coding | DAPK2 | No | No | 23604 | Q9UIK4 |
TVIS20067653 | HPV | ENSG00000035664.11 | protein_coding | DAPK2 | No | No | 23604 | Q9UIK4 |
TVIS20052311 | HPV | ENSG00000035664.11 | protein_coding | DAPK2 | No | No | 23604 | Q9UIK4 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | DAPK2 |
---|---|
DrugBank ID | DB12010 |
Drug Name | Fostamatinib |
Target ID | BE0009428 |
UniProt ID | Q9UIK4 |
Regulation Type | inhibitor |
PubMed IDs | 26516587 |
Citations | Rolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4. |
Groups | Approved; Investigational |
Direct Classification | Methoxyanilines |
SMILES | COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC |
Pathways | |
PharmGKB | |
ChEMBL | CHEMBL2103830 |